Literature DB >> 8601740

Pemphigus vulgaris antigen (desmoglein 3) is localized in the lower epidermis, the site of blister formation in patients.

M Amagai1, P J Koch, T Nishikawa, J R Stanley.   

Abstract

In Patients with pemphigus vulgaris, autoantibodies against the desmosomal glycoprotein desmoglein 3 (Dsg3) cause blisters due to loss of keratinocyte cell-cell adhesion in the basal and immediate suprabasal layer of the deeper epidermis, leaving the superficial epidermis intact. Autoantibodies from these patients, however, usually bind to the cell surface of keratinocytes throughout the entire epidermis, as determined by indirect immunofluorescence. To explain this apparent paradox, we immunoadsorbed pemphigus vulgaris sera with the extracellular domains of Dsg3 and desmoglein 1 (Dsg1) produced by insect cells infected with recombinant baculovirus. When adsorbed with extracellular domains of both Dsg3 and Dsg1, these sera no longer stained epidermis, demonstrating that most, if not all, of their cell surface reactivity can be attributed to antibodies against the extracellular domains of these desmogleins. Adsorption with only the Dsg1 extracellular domain left antibodies that stained only the basal and immediate suprabasal layers of the epidermis and immunoprecipitated only Dsg3, not Dsg1, from extracts of cultured cells synthesizing these molecules. In contrast, adsorption with only the Dsg3 extracellular domain left antibodies that stained only the more superficial epidermis and immunoprecipitated only Dsg1. These data localize Dsg3 exactly to the area in the epidermis where blisters occur in pemphigus vulgaris.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8601740     DOI: 10.1111/1523-1747.ep12343081

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  44 in total

1.  Plakoglobin rescues adhesive defects induced by ectodomain truncation of the desmosomal cadherin desmoglein 1: implications for exfoliative toxin-mediated skin blistering.

Authors:  Cory L Simpson; Shin-ichiro Kojima; Victoria Cooper-Whitehair; Spiro Getsios; Kathleen J Green
Journal:  Am J Pathol       Date:  2010-11-12       Impact factor: 4.307

2.  Evaluation of exposure of pemphigus vulgaris patients to Mycobacterium tuberculosis and Aspergillus fumigatus.

Authors:  R A Ali; R H Elsherif; M A Saleh; M H Ismail
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-07-11       Impact factor: 3.267

3.  IgG autoantibodies against desmocollin 3 in pemphigus sera induce loss of keratinocyte adhesion.

Authors:  David Rafei; Ralf Müller; Norito Ishii; Maria Llamazares; Takashi Hashimoto; Michael Hertl; Rüdiger Eming
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

Review 4.  Desmosomes: just cell adhesion or is there more?

Authors:  Ansgar Schmidt; Peter J Koch
Journal:  Cell Adh Migr       Date:  2007-01-26       Impact factor: 3.405

5.  Robust memory responses against influenza vaccination in pemphigus patients previously treated with rituximab.

Authors:  Alice Cho; Bridget Bradley; Robert Kauffman; Lalita Priyamvada; Yevgeniy Kovalenkov; Ron Feldman; Jens Wrammert
Journal:  JCI Insight       Date:  2017-06-15

Review 6.  Mechanisms of Disease: Pemphigus and Bullous Pemphigoid.

Authors:  Christoph M Hammers; John R Stanley
Journal:  Annu Rev Pathol       Date:  2016-02-22       Impact factor: 23.472

7.  Protective effect of intravenous immunoglobulin (IVIG) in an experimental model of pemphigus vulgaris.

Authors:  D Mimouni; M Blank; L Ashkenazi; Y Milner; M Frusic-Zlotkin; G J Anhalt; M David; Y Shoenfeld
Journal:  Clin Exp Immunol       Date:  2005-12       Impact factor: 4.330

8.  Nonsecretory IgA1 autoantibodies targeting desmosomal component desmoglein 3 in intraepidermal neutrophilic IgA dermatosis.

Authors:  J Wang; J Kwon; X Ding; J A Fairley; D T Woodley; L S Chan
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

9.  Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice.

Authors:  M Amagai; T Nishikawa; H C Nousari; G J Anhalt; T Hashimoto
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

10.  Targeted immunotherapy with rituximab leads to a transient alteration of the IgG autoantibody profile in pemphigus vulgaris.

Authors:  Ralf Müller; Nicolas Hunzelmann; Vera Baur; Guido Siebenhaar; Elke Wenzel; Rüdiger Eming; Andrea Niedermeier; Philippe Musette; Pascal Joly; Michael Hertl
Journal:  Dermatol Res Pract       Date:  2010-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.